Page last updated: 2024-11-07

androsterone and Prostatic Neoplasms, Castration-Resistant

androsterone has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research Excerpts

ExcerptRelevanceReference
"In castration-resistant prostate cancer patients, levels of androstenedione were significantly associated with testosterone level, while testosterone was the only steroid associated with dihydrotestosterone levels."1.72Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level. ( Caron, P; Guillemette, C; Lacombe, L; Lévesque, É; Morin, F; Neveu, B; Pouliot, F; Rouleau, M; Toren, P; Turcotte, V, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rouleau, M1
Neveu, B1
Caron, P1
Morin, F1
Toren, P1
Lacombe, L1
Turcotte, V1
Lévesque, É1
Guillemette, C1
Pouliot, F1

Other Studies

1 other study available for androsterone and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level.
    The Journal of urology, 2022, Volume: 208, Issue:6

    Topics: Androgen Antagonists; Androgens; Androstenedione; Androsterone; Dehydroepiandrosterone; Dihydrotesto

2022